chr1-248038329-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001385855.1(OR2L2):c.62G>A(p.Arg21Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385855.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2L2 | NM_001385855.1 | c.62G>A | p.Arg21Lys | missense_variant | 3/3 | ENST00000641771.1 | |
OR2L2 | NM_001004686.3 | c.62G>A | p.Arg21Lys | missense_variant | 2/2 | ||
OR2L13 | NM_001304535.3 | c.-18-61029G>A | intron_variant | ||||
OR2L13 | NM_175911.5 | c.-143-60322G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2L2 | ENST00000641771.1 | c.62G>A | p.Arg21Lys | missense_variant | 3/3 | NM_001385855.1 | P1 | ||
OR2L2 | ENST00000366479.4 | c.62G>A | p.Arg21Lys | missense_variant | 1/1 | P1 | |||
OR2L2 | ENST00000642011.1 | c.62G>A | p.Arg21Lys | missense_variant | 2/2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 2AN: 152156Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 250942Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135628
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461416Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727028
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2023 | The c.62G>A (p.R21K) alteration is located in exon 1 (coding exon 1) of the OR2L2 gene. This alteration results from a G to A substitution at nucleotide position 62, causing the arginine (R) at amino acid position 21 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at